Despite a high degree of structural similarity, it is known that MMP2 and MMP9 have distinct roles in the angiogenic switch and in cell migration, as they activate diverse signaling pathways. Indeed, inhibition of MMP2 and MMP9 can show beneficial or detrimental effects depending on the stage of tumor progression. Thus, the selective inhibition of gelatinases is of relevance for a successful drug lead, which has to be achieved despite the high structural similarity of the two gelatinases. Herein, the synthesis and evaluation of D-proline-derived hydroxamic acids containing amino appendages at C-4 as gelatinase inhibitors are reported. Inhibition assays enabled the identification of a > 200-fold selective MMP9 inhibitor when Lys was considered as a C-4 substituent, thus addressing gelatinase selectivity beyond the S1′ subsite, which is a major driver for selectivity. Molecular docking studies revealed the basic moiety of Lys as detrimental for inhibition of MMP2 as compared to MMP9.

Discovery of a D-pro-lys peptidomimetic inhibitor of MMP9 : Addressing the gelatinase selectivity beyond S1′ subsite / E. Lenci, A. Contini, A. Trabocchi. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - 30:20(2020 Oct 15), pp. 127467.1-127467.6. [10.1016/j.bmcl.2020.127467]

Discovery of a D-pro-lys peptidomimetic inhibitor of MMP9 : Addressing the gelatinase selectivity beyond S1′ subsite

A. Contini;
2020

Abstract

Despite a high degree of structural similarity, it is known that MMP2 and MMP9 have distinct roles in the angiogenic switch and in cell migration, as they activate diverse signaling pathways. Indeed, inhibition of MMP2 and MMP9 can show beneficial or detrimental effects depending on the stage of tumor progression. Thus, the selective inhibition of gelatinases is of relevance for a successful drug lead, which has to be achieved despite the high structural similarity of the two gelatinases. Herein, the synthesis and evaluation of D-proline-derived hydroxamic acids containing amino appendages at C-4 as gelatinase inhibitors are reported. Inhibition assays enabled the identification of a > 200-fold selective MMP9 inhibitor when Lys was considered as a C-4 substituent, thus addressing gelatinase selectivity beyond the S1′ subsite, which is a major driver for selectivity. Molecular docking studies revealed the basic moiety of Lys as detrimental for inhibition of MMP2 as compared to MMP9.
amino acids; angiogenesis; drug discovery; enzyme inhibition; matrix metalloproteinase; peptidomimetics
Settore CHIM/06 - Chimica Organica
15-ott-2020
Article (author)
File in questo prodotto:
File Dimensione Formato  
postprint.pdf

Open Access dal 16/10/2022

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 925.73 kB
Formato Adobe PDF
925.73 kB Adobe PDF Visualizza/Apri
1-s2.0-S0960894X20305783-main.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 4.47 MB
Formato Adobe PDF
4.47 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/760731
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 8
  • ???jsp.display-item.citation.isi??? 7
social impact